In apoE-knockout mice treated with olanzapine, liver lipid accumulation was increased remarkably (Chen et al., 2018). In that study, dyslipidemia elicited by olanzapine was improved by concomitant ECG and EGCG administration. This evidence concerns the gene APOE and metabolic syndrome.